BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 26, 1999
View Archived Issues
Genzyme General's Seprafilm approved in Europe for cardiac surgery
Read More
Growth factors shown to improve muscle healing in animal models
Read More
Merck terminates negotiations with Bioject
Read More
Biogen and Ontogeny extend hedgehog protein collaboration
Read More
Magainin reports interim results of squalamine trial
Read More
Two German pharmaceutical companies join forces in urology segment
Read More
Millennium Preventive Medicine and Becton Dickinson establish diagnostics alliance
Read More
Aurora enters screening agreement with Roche
Read More
Novel BK channel modulators developed at Bristol-Myers Squibb
Read More
Azacycloalkane derivatives for diabetes and related disorders patented by Synthelabo
Read More
Fujisawa's new hypoglycemic and hypolipidemic agents
Read More
CNS compounds from Merck acting on serotonergic system
Read More
Bayer claims oxazolidinones active against Gram-positive bacteria and mycobacteria
Read More
Clinically effective antiarthritic drug offered for licensing by KS Biomedix
Read More
Company Profile: Almirall Prodesfarma
Read More
New Vasogen technology protects against GVHD in animal model
Read More
C5a receptor antagonist with therapeutic potential in endotoxic shock, ARDS
Read More
Cubist reports new developments in antibiotic program
Read More
Eradication of H. pylori may prevent long-term NSAID-related ulcers
Read More
Nevirapine-containing triple combination therapy effective in advanced HIV disease or AIDS
Read More
Cortecs concludes phase III Macritonin trial
Read More
Matrix begins treating patients in phase II study of FMdC
Read More
Muse granted marketing approval in Germany
Read More
Rofecoxib up for advisory committee review this spring
Read More
InKine schedules pre-NDA meeting with FDA for INKP-100
Read More
Zimmer launches Orthovisc in Europe; prepares to begin North American trials
Read More
Worldwide strategic alliance established by Agennix and Santen for lactoferrin
Read More